Zobrazeno 1 - 10
of 113
pro vyhledávání: '"Ahmed O. Elzoghby"'
Autor:
Ahmed O. Elzoghby, Omar Samir, Hagar E. Emam, Ahmed Soliman, Riham M. Abdelgalil, Yomna M. Elmorshedy, Kadria A. Elkhodairy, Mahmoud L. Nasr
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 14, Iss 6, Pp 2475-2504 (2024)
Resistance to cancer immunotherapy is mainly attributed to poor tumor immunogenicity as well as the immunosuppressive tumor microenvironment (TME) leading to failure of immune response. Numerous therapeutic strategies including chemotherapy, radiothe
Externí odkaz:
https://doaj.org/article/6d6c91ef66764091953fcf37837f64d9
Autor:
Tasneem A. Nasser, Rawan Adel, Abdelrahman Badr, Mohamed Teleb, Adnan A. Bekhit, Kadria A. Elkhodairy, Ahmed S. Abdelhamid, Ahmed O. Elzoghby
Publikováno v:
ACS Omega, Vol 8, Iss 5, Pp 4491-4507 (2023)
Externí odkaz:
https://doaj.org/article/6b6db664bbf849828d0b4ec498a9671c
Autor:
Sarah Mokhtar, Sherine N. Khattab, Kadria A. Elkhodairy, Mohamed Teleb, Adnan A. Bekhit, Ahmed O. Elzoghby, Marwa A. Sallam
Publikováno v:
Frontiers in Chemistry, Vol 10 (2022)
While the treatment regimen of certain types of breast cancer involves a combination of hormonal therapy and chemotherapy, the outcomes are limited due to the difference in the pharmacokinetics of both treatment agents that hinders their simultaneous
Externí odkaz:
https://doaj.org/article/fe04ff82f0f549d8be95a7b4747131c4
Autor:
Huang-Ping Yu, Fu-Chao Liu, Ani Umoro, Zih-Chan Lin, Ahmed O. Elzoghby, Tsong-Long Hwang, Jia-You Fang
Publikováno v:
Journal of Nanobiotechnology, Vol 18, Iss 1, Pp 1-16 (2020)
Abstract Background Oleic acid (OA) is reported to show anti-inflammatory activity toward activated neutrophils. It is also an important material in nanoparticles for increased stability and cellular internalization. We aimed to evaluate the anti-inf
Externí odkaz:
https://doaj.org/article/7a7f14fb32f84d00a8e412b8e54cac33
Autor:
Mai Salah, Marwa A. Sallam, Mona A. Abdelmoneem, Mohamed Teleb, Kadria A. Elkhodairy, Adnan A. Bekhit, Asmaa F. Khafaga, Ahmed E. Noreldin, Ahmed O. Elzoghby, Sherine N. Khattab
Publikováno v:
Pharmaceutics, Vol 14, Iss 11, p 2404 (2022)
While breast cancer remains a global health concern, the elaboration of rationally designed drug combinations coupled with advanced biocompatible delivery systems offers new promising treatment venues. Herein, we repurposed rosuvastatin (RST) based o
Externí odkaz:
https://doaj.org/article/3f3479e12d9648bfb0c9dfb26e22c2bd
Autor:
Dina G. Zayed, Shaker M. Ebrahim, Maged W. Helmy, Sherine N. Khattab, Mohammed Bahey-El-Din, Jia-You Fang, Kadria A. Elkhodairy, Ahmed O. Elzoghby
Publikováno v:
Journal of Nanobiotechnology, Vol 17, Iss 1, Pp 1-19 (2019)
Abstract Background The rationale of this study is to combine the merits of both albumin nanoparticles and quantum dots (QDs) in improved drug tumor accumulation and strong fluorescence imaging capability into one carrier. However, premature drug rel
Externí odkaz:
https://doaj.org/article/e10ed0f943534da3ad9ba1bc1a90da46
Publikováno v:
Journal of Nanobiotechnology, Vol 16, Iss 1, Pp 1-14 (2018)
Abstract Background Cilomilast is a phosphodiesterase 4 (PDE4) inhibitor for treating inflammatory lung diseases. This agent has a narrow therapeutic index with significant adverse effects on the nervous system. This study was conducted to entrap cil
Externí odkaz:
https://doaj.org/article/8f20de41df2b4df78620f32caece9311
Autor:
Yomna M. Elmorshedy, Mohamed Teleb, Marwa A. Sallam, Kadria A. Elkhodairy, Mohammed Bahey-El-Din, Doaa A. Ghareeb, Shaymaa A. Abdulmalek, Shimaa A. H. Abdel Monaim, Adnan A. Bekhit, Ahmed O. Elzoghby, Fernando Albericio, Sherine N. Khattab
Publikováno v:
Biomacromolecules. 24:2149-2163
Autor:
Riham M. Abdelgalil, Sherine N. Khattab, Shaker Ebrahim, Kadria A. Elkhodairy, Mohamed Teleb, Adnan A. Bekhit, Marwa A. Sallam, Ahmed O. Elzoghby
Publikováno v:
ACS Omega. 8:5655-5671
Autor:
Riham M Abdelgalil, Yomna M Elmorshedy, Kadria A Elkhodairy, Mohamed Teleb, Adnan A Bekhit, Sherine N Khattab, Ahmed O Elzoghby
Publikováno v:
Nanomedicine (London, England).
Colorectal cancer (CRC) is one of the most devastating diseases worldwide. Immunotherapeutic agents for CRC treatment have shown limited efficacy due to the immunosuppressive tumor microenvironment (TME). In this context, various types of nanoparticl